KRRO vs PATH
Korro Bio, Inc. (KRRO) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Korro Bio, Inc. (KRRO) is a biotechnology company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported KRRO revenue for 2024-12-31 was $2.3M. Net income was -$83.6M. KRRO currently screens at market cap $159.8M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
KRRO currently screens at market cap $159.8M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the KRRO and PATH stock pages for the full models.
Not investment advice.